Maxion Therapeutics Funding: $72M Raised, Series A (2025)
Maxion Therapeutics is a Biotech company based in Cambridge, United Kingdom. It has raised $72M in total funding. Latest round: Series A.
Maxion Therapeutics funding overview
Maxion Therapeutics is a Biotech company based in Cambridge, United Kingdom. Maxion Therapeutics has raised $72M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2025. The round record for Maxion Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include General Catalyst, British Patient Capital, Solasta Ventures, Eli Lilly and Company, LifeArc Ventures, Monograph Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Maxion Therapeutics at a glance
Total raised
$72M
Latest round
Series A
Latest round date
March 2025
Industry
Biotech
Headquarters
Cambridge, United Kingdom
Notable investors
General Catalyst, British Patient Capital, Solasta Ventures, Eli Lilly and Company, LifeArc Ventures, Monograph Capital, BGF
Frequently asked about Maxion Therapeutics funding
How much has Maxion Therapeutics raised?
Maxion Therapeutics has raised $72M in total disclosed funding across the rounds on record.
Who has invested in Maxion Therapeutics?
General Catalyst, British Patient Capital, Solasta Ventures, Eli Lilly and Company, LifeArc Ventures, Monograph Capital are named among the investors backing Maxion Therapeutics.
What was the latest Maxion Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2025.
Where is Maxion Therapeutics based?
Maxion Therapeutics is based in Cambridge, United Kingdom.
What sector does Maxion Therapeutics operate in?
Maxion Therapeutics is tracked under Biotech from Cambridge, United Kingdom, with $72M in disclosed funding.
When did Maxion Therapeutics last raise?
The last disclosed Maxion Therapeutics round closed in March 2025 at Series A.
We update the Maxion Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Cambridge and their backers are listed below.
